The CEO of Moderna warned this Tuesday the European countries that the fact that they are dragging the negotiations for the acquisition of the new vaccine against covid-19 will delay the process of distribution and delivery of orders that they may do, since priority will be given to other countries that have already signed agreements with the company.
“It is obvious that, with the delay that is occurring, it will not limit the quantity of orders, but will delay its delivery”, assured Stephane Bancel in an interview with AFP.
Moderna announced this week that its experimental vaccine is about 95% effective in protecting people against the coronavirus, which has raised hopes for an end to the pandemic even more, after last week, the American company Pfizer had Similar results have been released in relation to the vaccine it is developing.
Stephane Bancel said the United States has already reserved 100 million doses since the beginning of August and several million doses are now stored pending approval from the United States regulator, which is expected to appear in December.
During the summer, Moderna started talks with the European Commission to purchase 80 million doses of the vaccine, but so far no contract has been signed, guaranteed Bancel at the company’s headquarters in Cambridge, Massachusetts.
Since then, Moderna, which developed its drug in conjunction with the United States National Institutes of Health, has signed agreements to supply Canada, Japan, Israel, Qatar and the United Kingdom, he said.
– .
